advertisement

Topcon

Clinical and Experimental Optometry 18

Showing records 1 to 18 | Display all abstracts in Clinical and Experimental Optometry

80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Fingeret M
Clinical and Experimental Optometry 2019; 102: 541-550
79326 Relating optical coherence tomography to visual fields in glaucoma: structure-function mapping, limitations and future applications
Denniss J
Clinical and Experimental Optometry 2019; 102: 291-299
80002 Anterior segment optical coherence tomography and its clinical applications
Wang SB
Clinical and Experimental Optometry 2019; 102: 195-207
79714 An evidence-based approach to the routine use of optical coherence tomography
Ly A
Clinical and Experimental Optometry 2019; 102: 242-259
79722 Intraocular pressure changes in eyes with small incision lenticules and laser in situ keratomileusis
Wang KJ
Clinical and Experimental Optometry 2019; 102: 399-405
79714 An evidence-based approach to the routine use of optical coherence tomography
Phu J
Clinical and Experimental Optometry 2019; 102: 242-259
79722 Intraocular pressure changes in eyes with small incision lenticules and laser in situ keratomileusis
Wang WW
Clinical and Experimental Optometry 2019; 102: 399-405
80002 Anterior segment optical coherence tomography and its clinical applications
Cornish EE
Clinical and Experimental Optometry 2019; 102: 195-207
79326 Relating optical coherence tomography to visual fields in glaucoma: structure-function mapping, limitations and future applications
Turpin A
Clinical and Experimental Optometry 2019; 102: 291-299
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Gaddie IB
Clinical and Experimental Optometry 2019; 102: 541-550
79722 Intraocular pressure changes in eyes with small incision lenticules and laser in situ keratomileusis
Tsai CL
Clinical and Experimental Optometry 2019; 102: 399-405
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Bloomenstein M
Clinical and Experimental Optometry 2019; 102: 541-550
80002 Anterior segment optical coherence tomography and its clinical applications
Grigg JR
Clinical and Experimental Optometry 2019; 102: 195-207
79326 Relating optical coherence tomography to visual fields in glaucoma: structure-function mapping, limitations and future applications
McKendrick AM
Clinical and Experimental Optometry 2019; 102: 291-299
79714 An evidence-based approach to the routine use of optical coherence tomography
Katalinic P
Clinical and Experimental Optometry 2019; 102: 242-259
80002 Anterior segment optical coherence tomography and its clinical applications
McCluskey PJ
Clinical and Experimental Optometry 2019; 102: 195-207
79722 Intraocular pressure changes in eyes with small incision lenticules and laser in situ keratomileusis
Wang IJ
Clinical and Experimental Optometry 2019; 102: 399-405
79714 An evidence-based approach to the routine use of optical coherence tomography
Kalloniatis M
Clinical and Experimental Optometry 2019; 102: 242-259

Issue 20-2

Change Issue


advertisement

Oculus